Cargando…
Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration
Erythropoietin (EPO), a humoral regulator of erythropoiesis and replacement therapy for selected red blood cell disorders in EPO-deficient patients, has been implicated in a wide range of activities on diverse cell, tissue, and organ types. EPO signals via two receptors, one comprising EPO receptor...
Autor principal: | Broxmeyer, Hal E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570099/ https://www.ncbi.nlm.nih.gov/pubmed/23401569 http://dx.doi.org/10.1084/jem.20122760 |
Ejemplares similares
-
RHEX in the mix of erythropoietin signaling molecules
por: Broxmeyer, Hal E.
Publicado: (2014) -
Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer
por: Aapro, M, et al.
Publicado: (2012) -
Considerations for the Use of Phage Therapy in Clinical Practice
por: Suh, Gina A., et al.
Publicado: (2022) -
Considerations for Dose Selection and Clinical Pharmacokinetics/Pharmacodynamics for the Development of Antibacterial Agents
por: Rizk, M. L., et al.
Publicado: (2019) -
Aerobiology: Experimental Considerations, Observations, and Future Tools
por: Haddrell, Allen E., et al.
Publicado: (2017)